Zepbound has emerged as a highly effective new weight loss drug and has been FDA-approved for treating obesity
The FDA has issued a warning about medications containing compounded semaglutide marketed for Type 2 diabetes and weight loss
It makes it appropriate for a different use case: the person who already controls their diet, exercises consistently, and wants a modest additional push in fat mobilization without the gastrointestinal side effects, nausea, or hormonal disruption that come with GLP-1 agonists
Youve heard about generic semaglutide costing a fraction of brand-name prices
McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ et al
[145] Any tablets showing signs of deterioration should be discarded and replaced